Quarterly report · Q3
2796.TEDINET S100T8YK
Period2023-06-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥40.7bn | 2023-06-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥863m | 2023-06-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥896m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥799m | 2023-06-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥890m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥761m | 2023-06-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥722m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥177m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥333m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥208m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥187m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥218m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥26.4bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥23.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥22.9bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.5bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.2bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥17.22 | 2023-06-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.42 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.45 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.24 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.45 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥16.48 | 2023-06-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.89 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥16.89 | 2022-06-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 29.0% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.4% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2024-02-29 | ¥593m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2024-02-29 | ¥593m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2024-02-29 | ¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2024-02-29 | −¥250m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥6.2bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥6.2bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥45m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥456m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥456m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥33m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥33.1bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥33.1bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥83m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥40.1bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥40.1bn |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2024-02-29 | ¥40.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2024-02-29 | ¥40.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2023-02-28 | ¥37m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥226m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥170m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥56m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥70m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 396
| Item | Context | Value | Unit |
|---|---|---|---|
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所 スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない 当社における標準となる株式 単元株式数100株 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)同上 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)ファーマライズホールディングス株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都中野区中央１丁目38－１ | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |